TY  - CONF

T1  - Abstract OT2-6-02: Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): A global, placebo-controlled, randomized, double-blind, phase 3 clinical trial

JO  - Ongoing Trials Poster Session Abstracts

PY  - 2013/12/15

AU  - Goss PE

AU  - Barrios CH

AU  - Chan A

AU  - Finkelstein DM

AU  - Iwata H

AU  - Martin M

AU  - Braun A

AU  - Zhou Y

AU  - Maniar T

AU  - Coleman RE

ED  - 

DO  - DOI: 10.1158/0008-5472.sabcs13-ot2-6-02

PB  - American Association for Cancer Research

Y2  - 2025/10/10

ER  -